FogPharma: Funding, Investors & Team (Oct 2026)
FogPharma was founded by Greg Verdine, a leader in creating new drugs for previously untreatable targets. The company develops cell-penetrating mini proteins that can target diseases beyond traditional treatments. With a team of experts in cancer research and therapy, FogPharma is dedicated to creating innovative cancer treatments. The company receives financial backing from a diverse group of investors and has a strong support network of founders, employees, and patients working toward the goal of improving cancer care. FogPharma is committed to delivering groundbreaking medicines to patients and improving their quality of life.
FogPharma has raised $323M across 2 funding rounds on record, the most recent an undisclosed round of $145M announced in Mar 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
FogPharma Company Profile and Key Stats
Latest funding round on record: Mar 2024.
FogPharma Funding Rounds
FogPharma raised $178M in a Series D announced in Nov 2022.
1.3 years later, an undisclosed round of $145M was announced in Mar 2024.
FogPharma Founders and Leadership Team
Contact details for the FogPharma team: 1 of 1 has an email address on file.
Start 14-day free trial →FogPharma Funding Compared to Other Biotechnology Startups
FogPharma's latest round of $145M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like FogPharma in Biotechnology and Cambridge
Companies Similar to FogPharma
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
FogPharma Funding FAQs
What does FogPharma do?
FogPharma was founded by Greg Verdine, a leader in creating new drugs for previously untreatable targets. The company develops cell-penetrating mini proteins that can target diseases beyond traditional treatments. With a team of experts in cancer research and therapy, FogPharma is dedicated to creating innovative cancer treatments. The company receives financial backing from a diverse group of investors and has a strong support network of founders, employees, and patients working toward the goal of improving cancer care. FogPharma is committed to delivering groundbreaking medicines to patients and improving their quality of life.
How much funding has FogPharma raised?
FogPharma has raised $323M across 2 rounds on record. The most recent is an undisclosed round of $145M announced in Mar 2024.
When did FogPharma last raise funding?
FogPharma's most recent funding round on record is an undisclosed round of $145M, announced in Mar 2024.
Who founded FogPharma?
FundedIQ lists Weiqing Zhou (Founder) at FogPharma.
Where is FogPharma headquartered?
FogPharma is based in Cambridge, Massachusetts, United States.
How many employees does FogPharma have?
FogPharma is in the 101-250 employee band.
How does FogPharma's funding compare to other Biotechnology startups?
FogPharma's latest round of $145M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's FogPharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for FogPharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.